Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Endoscopy ; 36(2): 183-5, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-14765318

RESUMO

Dieulafoy's lesion is an arterial malformation in the subumucosal layer of the gastrointestinal tract that can cause massive bleeding. The esophagus is not a common location for this lesion. We present here a first report of Dieulafoy's lesion of the esophagus correctly diagnosed and successfully treated by the endoscopic injection of N-butyl-2-cyanoacrylate.


Assuntos
Malformações Arteriovenosas/diagnóstico , Embucrilato/análogos & derivados , Embucrilato/administração & dosagem , Esôfago/irrigação sanguínea , Hemorragia Gastrointestinal/terapia , Hemostase Endoscópica/métodos , Adesivos Teciduais/administração & dosagem , Idoso , Artérias/anormalidades , Malformações Arteriovenosas/complicações , Malformações Arteriovenosas/terapia , Diagnóstico Diferencial , Hemorragia Gastrointestinal/etiologia , Hematemese/etiologia , Hematemese/terapia , Humanos , Masculino , Resultado do Tratamento
2.
Br J Cancer ; 89(11): 2116-21, 2003 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-14647147

RESUMO

If oesophageal carcinoma is detected in the superficial stage, the prognosis is better than for advanced oesophageal carcinoma. But the factors which predict the prognosis and treatment policy remain unclear. Matrix metalloproteinase-7 (MMP-7) and matrix metalloproteinase-9 (MMP-9) have been reported to have close associations with tumour invasion and metastasis. In this study, we retrospectively studied the relations between MMP-7 and MMP-9 expression in immunohistochemistry, clinicopathologic factors, and prognosis in 55 superficial oesophageal carcinomas. MMP-7 and MMP-9 expression occurred in 23.6% and 47.3% of the patients, respectively. MMP-7 expression was significantly correlated with the presence of nodal metastasis (P=0.004). MMP-9 expression was significantly correlated with the depth of tumour invasion (P=0.004), lymphatic permeation (P=0.001), nodal metastasis (P=0.049), and pathologic differentiation grade (P=0.003). By the log-rank test, MMP-7 expression and MMP-9 expression on the invasive front were related to the prognosis. In multivariate analysis, MMP-9 expression on the invasive front was an independent prognostic indicator. The combined expression of MMP-7 and MMP-9 may be a good marker for the degree of malignancy of oesophageal cancer and for the presence of lymphatic metastasis.


Assuntos
Adenocarcinoma/enzimologia , Carcinoma de Células Escamosas/enzimologia , Neoplasias Esofágicas/enzimologia , Metaloproteinase 7 da Matriz/metabolismo , Metaloproteinase 9 da Matriz/metabolismo , Adulto , Idoso , Feminino , Humanos , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Prognóstico , Análise de Sobrevida
3.
J Gastroenterol ; 36(5): 350-3, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11388400

RESUMO

Fulminant hepatic failure (FHF) usually has a fatal prognosis without liver transplantation. We describe the case of a woman who developed FHF, and was evaluated as a candidate for liver transplantation, but who was cured without transplantation through intensive medical care that included glucagon-insulin therapy, methylprednisolone pulse therapy, interferon beta and lamivudine administration, cyclosporine administration, and high-volume hemodiafiltration and plasma exchange. In a patient with FHF who is a candidate for liver transplantation but for whom the transplantation cannot be performed for some reason, intensive medical therapy, including regeneration-promoting therapy, immunosuppressive therapy, antiviral therapy, and vigorous hepatic support, should be carried out.


Assuntos
Antivirais/uso terapêutico , Hepatite B/complicações , Falência Hepática/terapia , Ciclosporina/uso terapêutico , Feminino , Hemodiafiltração/métodos , Humanos , Interferon beta/uso terapêutico , Falência Hepática/diagnóstico , Falência Hepática/virologia , Transplante de Fígado , Metilprednisolona/uso terapêutico , Pessoa de Meia-Idade , Troca Plasmática/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA